Green Arrow Capital Management’s Boston Scientific BSX Stock Holding History

Green Arrow Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-82,724	Closed	-$1.12M	–	178
2014 Q1	$1.12M	Sell	82,724 -195,776	-70%	-$2.57M	0.09%	185
2013 Q4	$3.35M	Sell	278,500 -221,500	-44%	-$2.62M	0.24%	132
2013 Q3	$5.87M	Sell	500,000 -100,000	-17%	-$1.08M	0.44%	75
2013 Q2	$5.56M	Buy	+600,000	New	+$5.09M	0.45%	67

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Green Arrow Capital Management's BSX Position: Q2 2014 in Review

Green Arrow Capital Management sold out of Boston Scientific (BSX) in Q2 2014, closing a stake of 82,724 shares — an estimated $1.12M sold.

Green Arrow Capital Management first reported a position in BSX in Q2 2013 and held it in 4 quarters. The position peaked at $5.87M in Q3 2013. 458 funds tracked by Wall St. Rank hold BSX as of Q2 2014.

Green Arrow Capital Management reported no remaining Boston Scientific position as of Q2 2014 after selling out during the quarter.
Green Arrow Capital Management sold 82,724 Boston Scientific shares in Q2 2014, an estimated $1.12M.
Green Arrow Capital Management first reported a position in Boston Scientific in Q2 2013 and held it in 4 quarters.
Green Arrow Capital Management's Boston Scientific position peaked at $5.87M in Q3 2013.
458 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2014.

Based on Green Arrow Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.